Comparison between the Plasma Levels of Long Noncoding RNA BDNF-AS in Patients with Alzheimer\'s disease and Healthy Subjects
BACKGROUND AND OBJECTIVE: Diagnosis of Alzheimer's disease usually occurs when serious damages have occurred in the brain and common treatments are ineffective in preventing it. One of the RNAs involved in Alzheimer's disease is a long noncoding RNA, called BDNF antisense (BDNF-AS). The ai...
Main Authors: | R Azizi Aghali, M Khalaj, N Zeinalzadeh, MA Hosseinpour Feizi, M Farhoudi, M Talebi |
---|---|
Format: | Article |
Language: | English |
Published: |
Babol University of Medical Sciences
2018-04-01
|
Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul |
Subjects: | |
Online Access: | http://jbums.org/browse.php?a_code=A-10-3670-1&slc_lang=en&sid=1 |
Similar Items
-
proBDNF is modified by advanced glycation end products in Alzheimer’s disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing
by: Catherine Fleitas, et al.
Published: (2018-11-01) -
BDNF and cognitive function in Alzheimer’s disease
by: A. Sidenkova
Published: (2022-06-01) -
Investigating the association of Val/Met polymorphism of the BDNF gene with the incidence of disease in patients with Alzheimer and comparison with healthy elderly people in Iran
by: Fatemeh Mirzaii-Fini, et al.
Published: (2019-02-01) -
Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
by: Francheska Delgado-Peraza, et al.
Published: (2023-09-01) -
Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease
by: Ioanna Zota, et al.
Published: (2024-09-01)